Ancillary supplies are essential to protocol execution, but inconsistent supply, limited site readiness, or regulatory missteps can compromise timelines. As clinical trial protocols grow more specialized and geographically dispersed, biotech and biopharma companies are reevaluating how they manage ancillary sourcing, oversight, and delivery.
In this webinar, Molly Isermann, Senior Manager of Product Management, Clinical Ancillary Management at Thermo Fisher Scientific, shares how our clinical ancillary management (CAM) services support patient-first readiness, reduce supply-related delays, and adapt to the evolving needs of global studies. Molly has worked at Thermo Fisher for over 15 years, supporting customers across various industries with their laboratory and clinical supply, capital equipment, and service needs. As part of the clinical ancillary management team, she ensures customers receive the highest standard of CAM product and service offerings for their clinical trials.
Highlights from this webinar include: